Company profile: ConcertAI
1.1 - Company Overview
Company description
- Provider of AI-powered SaaS medical research tools and integrated real-world data solutions for oncology. Offerings include AI-enriched datasets for clinical and outcomes research, regulatory-grade external control arms, pragmatic trials, post-approval studies, virtual EMR-claims registries, and regulatory research with custom real-world data abstraction and scientific consultation.
Products and services
- External Control Arms: Supplies regulatory-grade real-world data and scientific expertise for designing and submitting successful external control arms in clinical trials
- Accelerated RWE: Delivers large, AI-enriched datasets for oncology clinical and outcomes research, enabling faster research and improved patient outcomes
- Pragmatic Trials: Leverages real-world data to support pragmatic trials that reflect actual standard of care and support regulatory goals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ConcertAI
Paige
HQ: United States
Website
- Description: Provider of software to advance the diagnosis, treatment, and biomarker discovery for cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paige company profile →
ClinApps
HQ: United States
Website
- Description: Provider of software development and consulting services, creating state-of-the-art systems for the pharmaceutical and biotechnology industries. Established in 1999 with international offices, the company leverages a full-time staff of highly skilled industry professionals to deliver high-quality end-to-end solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinApps company profile →
IPM.ai
HQ: United States
Website
- Description: Provider of HIPAA-certified machine learning infrastructure for biopharma, delivering AI-powered patient finding, insights-as-a-service, and a system of insight using real-world data to optimize drug development and commercialization. Services include clinical study recruitment, market assessment, and patient journey mapping for specialty and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPM.ai company profile →
Epinomics
HQ: United States
Website
- Description: Provider of deep analytics and proprietary technology to decode the epigenome (the "living genome"), advancing personalized health through scientific research and clinical application development in personalized medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epinomics company profile →
Nonlinear Dynamics
HQ: United Kingdom
Website
- Description: Provider of scientific software for proteomics, metabolomics, genomics, drug discovery, and bioinformatics, including Progenesis QI for LC-MS analysis of small molecules, Progenesis QI for Proteomics for label-free LC-MS protein quantification and identification, and the Natural Product Atlas Library with structural data on microbially derived natural products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nonlinear Dynamics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ConcertAI
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ConcertAI
2.2 - Growth funds investing in similar companies to ConcertAI
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ConcertAI
4.2 - Public trading comparable groups for ConcertAI
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →